MedTrace Logo

Effectiveness of Exercise in the Treatment of Upper Cross Syndrome

NCT06185322 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-29

No results posted yet for this study

Summary

Upper cross syndrome (UCS) is a common postural deformity characterized by a change in neck, torso and shoulder muscle activity and shoulder movement. UCS results in a shortening of the upper back and chest muscles as well as the muscles which provide movement to the shoulder blade. This is accompanied by weakness of the upper back muscles, shoulder blade stabilizor muscles and deep neck muscles. The resultant muscle imbalance leads to elevation of the shoulders, elongation of the neck and rounding of the back.

The change in posture which occurs in UCS changes the biomechanics of the neck and upper back and can results in neck pain, adverse effects on daily activities and productivity. To date, studies have been done on treatment of elongation of the neck using muscle relaxation techniques and manipulation of the local structures. To date, there is no study which investigates the efficacy of a specific exercise program targeting the muscles affected by UCS. The aim of this study is to investigate the effects of UCS-specific exercises on neck-back pain, cervical posture, disability and quality of life.

Conditions

  • Upper Cross Syndrome

Interventions

OTHER

Physical therapy program with upper cross syndrome specific exercises

Ten physical therapy sessions consisting of electrotherapy and upper cross syndrome -specific exercise program.

OTHER

Physical therapy program with conventional neck strengthening exercises

Ten physical therapy sessions consisting of electrotherapy and conventional neck strenthening exercises

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-30
Completion
2025-01-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06185322 on ClinicalTrials.gov